Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bicycle Therapeutics (BCYC) Non-Current Deferred Tax Liability: 2022-2023

  • Bicycle Therapeutics' Non-Current Deferred Tax Liability fell 23.10% to $3.4 million in Q4 2023 from the same period last year, while for Dec 2023 it was $3.4 million, marking a year-over-year decrease of 23.10%. This contributed to the annual value of $3.4 million for FY2023, which is 23.10% down from last year.
  • Latest data reveals that Bicycle Therapeutics reported Non-Current Deferred Tax Liability of $3.4 million as of Q4 2023, which was down 23.10% from $4.4 million recorded in Q4 2022.
  • Bicycle Therapeutics' Non-Current Deferred Tax Liability's 5-year high stood at $4.4 million during Q4 2022, with a 5-year trough of $3.4 million in Q4 2023.
  • In the last 2 years, Bicycle Therapeutics' Non-Current Deferred Tax Liability had a median value of $3.9 million in 2022 and averaged $3.9 million.
  • Data for Bicycle Therapeutics' Non-Current Deferred Tax Liability shows a maximum YoY decreased of 23.10% (in 2023) over the last 5 years.
  • Quarterly analysis of 2 years shows Bicycle Therapeutics' Non-Current Deferred Tax Liability stood at $4.4 million in 2022, then declined by 23.10% to $3.4 million in 2023.